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Protein-ligand and protease-inhibitor interactions are subjects of great 
importance in structural biology and proteomics, and by the numerous applicative 
related issues, including drug-discovery. Many of the achievements to be fulfilled for 
these subjects have also been previously envisaged for general proteomics, as high 
sensitivity, highthroughput and discriminative capability, in-vivo/ex-vivo monitoring 
and quantitativeness. Few experimental approaches are able to fulfil such characteristics, 
of which mass spectrometry (MS) is one with focused active research on such aspects in 
the last decade. 
We selected MALDI-Tof MS variants to develop fast and simple approaches for 
such a purpose, using proteases and protease inhibitor molecules as models [1,2]. 
Initially only pair-waise interactions were characterized in vitro, with standard or high-
mass special detectors [3,4]. This has been subsequently extended to crude and complex 
biological extracts [2,5], particularly those originated from invertebrates which 
constitute more than 95% of the animal phyla, with very little data at the genomics, 
proteomics and structural biology levels. 
In the present communication we shall describe our recent results in such a 
field. Also, our trends and attempts to expand equivalent procedures to detect and 
analyze such molecules and interactions by "MALDI-Imaging-Mass spectrometry" 
(MALDI-IMS) [6], a technology that we are offering as a Service from our Institution. 
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